The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Research works printed but not linked: 23
- FitzGerald, 2001, The coxibs, selective inhibitors of cyclooxygenase-2, New Engl J Med, 345, 433, 10.1056/NEJM200108093450607 · DOI · Paper page
- Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, New Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 · DOI · Paper page
- Schnitzer, 2004, Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial, Lancet, 364, 665, 10.1016/S0140-6736(04)16893-1 · DOI · Paper page
- Solomon, 2005, Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention, New Engl J Med, 352, 1071, 10.1056/NEJMoa050405 · DOI · Paper page
- Kearney, 2006, Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials, BMJ, 332, 1302, 10.1136/bmj.332.7553.1302 · DOI · Paper page
- Capone, 2004, Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects, Circulation, 109, 1468, 10.1161/01.CIR.0000124715.27937.78 · DOI
- McGettigan, 2011, Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies, PLoS Med, 8, e1001098, 10.1371/journal.pmed.1001098 · DOI · Paper page
- Garcia Rodriguez, 2008, Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population, J Am Coll Cardiol, 52, 1628, 10.1016/j.jacc.2008.08.041 · DOI · Paper page
- Robinson, 2002, Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed, Int J Epidemiol, 31, 150, 10.1093/ije/31.1.150 · DOI · Paper page
- 1994, Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 · DOI · Paper page
- Glenny, 2005, Indirect comparisons of competing interventions, Health Technol Assess, 9, 1, 10.3310/hta9260 · DOI · Paper page
- Trelle, 2011, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis, BMJ, 342, c7086, 10.1136/bmj.c7086 · DOI · Paper page
- Ofman, 2002, A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs, J Rheumatol, 29, 804
- Rostom, 2007, Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review, Clin Gastroenterol Hepatol, 5, 818, 10.1016/j.cgh.2007.03.011 · DOI · Paper page
- Ott, 2003, Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery, J Thorac Cardiovasc Surg, 125, 1481, 10.1016/S0022-5223(03)00125-9 · DOI · Paper page
- Nussmeier, 2005, Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery, New Engl J Med, 352, 1081, 10.1056/NEJMoa050330 · DOI · Paper page
- Grosser, 2010, Emotion recollected in tranquility: lessons learned from the COX-2 saga, Annu Rev Med, 61, 17, 10.1146/annurev-med-011209-153129 · DOI · Paper page
- Song, 2003, Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses, BMJ, 326, 472, 10.1136/bmj.326.7387.472 · DOI · Paper page
- Solomon, 2008, Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis, Circulation, 117, 2104, 10.1161/CIRCULATIONAHA.108.764530 · DOI · Paper page
- Capone, 2005, Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects, J Am Coll Cardiol, 45, 1295, 10.1016/j.jacc.2005.01.045 · DOI · Paper page
- Meek, 2013, Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study, Eur J Clin Pharmacol, 69, 365, 10.1007/s00228-012-1370-y · DOI
- Capone, 2007, Human pharmacology of naproxen sodium, J Pharmacol Exp Ther, 322, 453, 10.1124/jpet.107.122283 · DOI
- Bhatt, 2008, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, 52, 1502, 10.1016/j.jacc.2008.08.002 · DOI · Paper page
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Hypoalbuminemia: Pathogenesis and Clinical Significance
Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 382
- Issue
- 9894
- Pages
- 769-779
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1599185368
- Cited by
- 1,802
- References
- 3
- FWCI
- 102.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- British Heart Foundation
- BHF Centre of Research Excellence, Oxford (RE/08/04)
- Medical Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. https://app.cochat.ai/papers/10.1016/s0140-6736(13)60900-9
- The paper
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. (2013). The Lancet. https://doi.org/10.1016/s0140-6736(13)60900-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
